UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Revising your budget at the right moments keeps finances aligned with goals. This guide covers timing, criteria, and practical tweaks.
28,655 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Morgan Stanley capped redemptions at a private income fund after a surge in withdrawals, fueling a Reddit-fueled sell...
Two CoinDCX co-founders were arrested by Indian police amid a fraud probe. The company denies wrongdoing and blames i...
A $225 million merger unites Major League Pickleball with Carvana's PPA Tour, forming Pickleball Inc. and signaling a...
Crypto traders are weighing ripple (xrp) solana (sol) as summer enters. The rivals push higher, but investors cite di...
Lenders are racing to scale content with AI, but a growing wave of complaints cites a loss of trust and rising compli...
When a chief financial officer liquidates shares, investors pay attention. This article digs into maplight's just sol...
The Federal Reserve will solicit public feedback on broadening master account access to more crypto and fintech firms...
A sudden rise in sweetgreen stock often stirs chatter among traders and fans alike. This article explains the common ...
Canada is urging a 16-year renewal of the USMCA with the United States and Mexico, signaling a push for long-term cer...
A national study shows a widening gap between expected and actual retirement savings, with most households lacking a ...
June market swings have hit chip names hard, but the smarter money is shifting toward a single AI-dominant tech heavy...